Cognizant Technology Solutions Corporation (CTSH) financials
NASDAQ · Technology · Information Technology Services · 356,700 employees · CEO Ravi Kumar Singisetti
- Price
- $65.11 +4.14%
- Market cap
- $29.1B
- Enterprise value
- $29.7B
- Last report
- Q3 '26 filed 2026-10-29
- Next report
- 2027-02-03 EPS est. $1.51
Valuation & key figures
- Market cap
- $29.1B EV $29.7B
- Revenue
- $21.9B Trailing 12 months
- Revenue growth
- +5% FY2026 consensus
- Profit margin
- 11.8% Net income / revenue, TTM
- P/E
- 11.9× Forward 11.3× (FY2026)
- P/S
- 1.3× Price / sales, TTM
- EV / EBITDA
- 7.2× TTM
- Free cash flow
- $2.36B Trailing 12 months
- Net income
- $2.57B Trailing 12 months
- Revenue estimate
- $22.1B FY2026 consensus
- Earnings
- 2027-02-03 Revenue est. $5.56B
- Dividend
- $1.30 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-10-29): revenue in line, EPS beat by 2.1%Revenue $5.66B vs $5.64B expected (+0.3%); EPS $1.49 vs $1.46 (+2.1%).
- Revenue growth slowing: 4.6% year on yearQ3 '26 revenue $5.66B, against an average of 5.7% over the four quarters before.
- Operating margin 15.6% (TTM), -0.2 pp on a year agoOperating income grew 3.9% while revenue grew 5.0%.
- Capex 1.5% of revenue (a year ago 1.4%)$331M invested in the last 4 quarters (+12.6% on a year earlier). Free cash flow $2.36B = 91.8% of net income.
- Returned $2.83B to shareholders = 119.8% of free cash flowBuybacks $2.22B (a year earlier $1.19B), dividends $616M, stock-based pay $123M (TTM). More than the free cash flow: paid from cash or debt.
- Diluted share count down 7.6% in a year450M diluted shares in Q3 '26, 487M a year earlier.
- Net debt $580MCash + short-term investments $1.55B, debt incl. leases $2.13B; a year ago net cash $1.18B.
- Financial Services: revenue +12.0%, margin 16.0% (was 16.8%)Fastest-growing reported segment in Q3 '26: operating income $283M on revenue $1.77B (from the segment note of the filing).
Last quarter: Q3 '26
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q3 '26 | Year ago | Change | |
|---|---|---|---|
| Revenue | $5.66B | $5.42B | +4.6% |
| Gross margin | 33.8% | 33.9% | -0.1 pp |
| Operating income | $872M | $866M | +0.7% |
| Operating margin | 15.4% | 16.0% | -0.6 pp |
| Net income | $627M | $274M | +128.8% |
| Diluted EPS | $1.39 | $0.56 | +148.2% |
| Operating cash flow | $1B | $1.23B | -18.2% |
| Capex | $79M | $67M | +17.9% |
| Free cash flow | $925M | $1.16B | -20.3% |
| R&D | $0 | $0 | – |
| Stock-based compensation | $50M | $47M | +6.4% |
Reported vs consensus
2026-10-29| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | $5.66B | $5.64B | +0.3% |
| EPS (as estimated) | $1.49 | $1.46 | +2.1% |
From the report of 2026-10-29 for Q3 '26: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyRevenue by business line
stacked, quarterly| Segment | Q3 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| Financial Services | $1.77B | +12.0% | 31.2% | $6.73B | +11.8% | |
| Healthcare Segment | $1.59B | -1.1% | 28.0% | $6.36B | +1.5% | |
| Products and Resources | $1.37B | -0.9% | 24.2% | $5.33B | +1.3% | |
| Communication, Media and Technology | $939M | +10.5% | 16.6% | $3.47B | +5.0% |
Revenue by region
share of total| Segment | Q3 '26 | y/y | Share | TTM | TTM y/y | 12 quarters |
|---|---|---|---|---|---|---|
| North America | $4.26B | +5.7% | 75.2% | $16.4B | +5.2% | |
| Europe | $1.06B | +1.4% | 18.7% | $4.14B | +5.3% | |
| Other Regions | $349M | +1.2% | 6.2% | $1.33B | +1.5% |
Segment profits
Operating income per reported segment, read from the segment note of each 10-Q / 10-K (the profit split most data feeds leave out).
Segments in Q3 '26
| Segment | Revenue | y/y | Operating income | y/y | Margin | Margin a year ago | TTM operating income |
|---|---|---|---|---|---|---|---|
| Financial Services | $1.77B | +12.0% | $283M | +6.8% | 16.0% | 16.8% | $1.29B |
| Health Sciences | $1.59B | -1.1% | $321M | +3.2% | 20.2% | 19.4% | $1.09B |
| Productsand Resources | $1.37B | -0.9% | $187M | +5.1% | 13.6% | 12.9% | $793M |
| Communications Media And Technology | $939M | +10.5% | $132M | +17.9% | 14.1% | 13.2% | – |
| Communications Mediaand Technology | – | – | – | – | – | – | – |
Operating income by segment
quarterlySegment operating margin
quarterlyFourth quarters are derived: the 10-K reports the full year, minus the three quarters of the 10-Qs.
Margins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- $2.69B
- Capex
- -$331M
- Buybacks
- -$2.22B
- Dividends
- -$616M
- Acquisitions
- -$1.31B
- Net debt issued
- $956M
- Stock-based compensation
- $123M
- Free cash flow
- $2.36B
- Returned to shareholders / FCF
- 119.8%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 11.9× | 17.6× | 12.9× – 21.9× |
| EV / EBITDA | 7.2× | 10.5× | 8.0× – 13.7× |
| EV / Sales | 1.4× | 1.9× | 1.5× – 2.5× |
| Price / FCF | 12.3× | 17.9× | 13.2× – 21.1× |
| Price / Book | 2.0× | 2.9× | 2.4× – 3.9× |
| FCF yield | 8.1% | 5.8% | 4.7% – 7.5% |
| Return on invested capital | 14.1% | 13.8% | 12.3% – 15.3% |
| Return on equity | 17.4% | 16.6% | 14.9% – 18.6% |
Analysts
Consensus target $65.75 (+1.0%)
range $51.00 – $82.00 · rating Buy
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2026 | $22.1B | +4.8% | $5.77 | +26.8% | 11.3× | 19 |
| FY2027 | $23B | +3.9% | $6.27 | +8.7% | 10.4× | 19 |
| FY2028 | $24B | +4.4% | $6.78 | +8.0% | 9.6× | 15 |
| FY2029 | $24.7B | +3.2% | $6.26 | -7.6% | 10.4× | 9 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Every reported line
All 239 figures Cognizant Technology Solutions Corporation tagged in its recent 10-Q / 10-K filings, with the official SEC label and definition - including the notes (leases, taxes, buybacks, employees, ...).
| Line (SEC label) | Latest quarter | Year ago | y/y | Latest FY | Prior FY | y/y |
|---|---|---|---|---|---|---|
| Accounts Payable, Current | $366M | $284M | +28.9% | $308M | $340M | -9.4% |
| Accounts Receivable, after Allowance for Credit Loss, Current | $4.85B | $4.39B | +10.5% | $4.44B | $4.06B | +9.4% |
| Accounts Receivable, Allowance for Credit Loss | $22M | $26M | -15.4% | $23M | $26M | -11.5% |
| Accounts Receivable, Allowance for Credit Loss, Writeoff | $4M | $7M | -42.9% | $14M | $18M | -22.2% |
| Accounts Receivable, Credit Loss Expense (Reversal) | $5M | $7M | -28.6% | $11M | $12M | -8.3% |
| Accrued Income Taxes, Current | $16M | $36M | -55.6% | $18M | $100M | -82.0% |
| Accrued Liabilities and Other Liabilities | $2.7B | $2.58B | +4.8% | $2.66B | $2.61B | +2.1% |
| Accrued Professional Fees, Current | $234M | $189M | +23.8% | $193M | $171M | +12.9% |
| Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | $3B2025-12-31 | $2.79B | +7.5% | $3B | $2.79B | +7.5% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | -$204M | -$64M | -218.8% | -$160M | -$296M | +45.9% |
| Additional Paid in Capital | $11M | $14M | -21.4% | $12M | $13M | -7.7% |
| Amortization of Intangible Assets | – | – | – | $218M | $188M | +16.0% |
| APIC, Share-based Payment Arrangement, Increase for Cost Recognition | $50M | $47M | +6.4% | $181M | $175M | +3.4% |
| Assets | $21.3B | $20.1B | +5.9% | $20.7B | $20B | +3.6% |
| Assets, Current | $8.09B | $8.09B | 0.0% | $7.82B | $7.5B | +4.2% |
| Business Combination, Pro Forma Information, Revenue of Acquiree since Acquisition Date, Actual | – | – | – | $384M2024-12-31 | $130M | +195.4% |
| Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation | – | – | – | $48M2024-12-31 | – | – |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents | $55M | – | – | $63M2024-12-31 | $20M | +215.0% |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other | $12M | – | – | $33M2024-12-31 | $12M | +175.0% |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables | $82M | – | – | $194M2024-12-31 | $10M | +1,840.0% |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities | – | – | – | $101M2024-12-31 | $27M | +274.1% |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other | $73M | – | – | – | – | – |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities | $74M | – | – | $37M2024-12-31 | – | – |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets | – | – | – | $45M2024-12-31 | – | – |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net | $1.4B | – | – | $1.79B2024-12-31 | $428M | +318.5% |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities | – | – | – | $33M2023-12-31 | $4M | +725.0% |
| Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other | $13M | – | – | – | – | – |
| Capitalized Computer Software, Accumulated Amortization | $252M2025-12-31 | $210M | +20.0% | $252M | $210M | +20.0% |
| Capitalized Computer Software, Amortization | – | – | – | $43M | $36M | +19.4% |
| Capitalized Computer Software, Gross | $377M2025-12-31 | $338M | +11.5% | $377M | $338M | +11.5% |
| Capitalized Contract Cost, Amortization | $13M | $19M | -31.6% | -$78M | -$89M | +12.4% |
| Capitalized Contract Cost, Impairment Loss | $2M | $0 | – | -$12M | -$2M | -500.0% |
| Capitalized Contract Cost, Net | $209M | $174M | +20.1% | $161M | $209M | -23.0% |
| Cash and Cash Equivalents, at Carrying Value | $1.52B | $2.34B | -35.3% | $1.9B | $2.23B | -14.8% |
| Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | $2M | -$47M | +104.3% | -$47M | -$16M | -193.8% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | $1.52B | $2.34B | -35.3% | $2.63B | $2.23B | +18.1% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | $477M | $545M | -12.5% | $403M | -$486M | +182.9% |
| Common Stock, Dividends, Per Share, Declared | $0.33 | $0.31 | +6.5% | $1.24 | $1.20 | +3.3% |
| Common Stock, Par or Stated Value Per Share | $0.01 | $0.01 | 0.0% | $0.01 | $0.01 | 0.0% |
| Common Stock, Shares Authorized | 1B | 1B | 0.0% | 1B | 1B | 0.0% |
| Common Stock, Shares, Issued | 448M | 483M | -7.2% | 479M | 495M | -3.2% |
| Common Stock, Shares, Outstanding | 448M | 483M | -7.2% | 479M | 495M | -3.2% |
| Common Stock, Value, Issued | $4M | $5M | -20.0% | $5M | $5M | 0.0% |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $624M | $167M | +273.7% | $2.37B | $2.04B | +16.1% |
| Contract with Customer, Asset, before Allowance for Credit Loss | $690M | $517M | +33.5% | $466M | $386M | +20.7% |
| Contract with Customer, Asset, Increase (Decrease) for Contract Acquired in Business Combination | – | – | – | $02024-12-31 | $9M | -100.0% |
| Contract with Customer, Asset, Reclassified to Receivable | $32M | $28M | +14.3% | -$371M | -$288M | -28.8% |
| Contract with Customer, Liability | $444M | $419M | +6.0% | $538M | $480M | +12.1% |
| Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination | $02025-12-31 | $0 | – | $0 | $12M | -100.0% |
| Contract with Customer, Liability, Revenue Recognized | $20M | $22M | -9.1% | -$416M | -$380M | -9.5% |
| Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization | $3.75B | $3.58B | +4.7% | $14B | $13B | +8.0% |
| Current Federal Tax Expense (Benefit) | – | – | – | $216M | – | – |
| Current Federal, State and Local, Tax Expense (Benefit) | – | – | – | $426M2024-12-31 | $522M | -18.4% |
| Current Foreign Tax Expense (Benefit) | – | – | – | $576M | $642M | -10.3% |
| Current Income Tax Expense (Benefit) | – | – | – | $931M | $1.07B | -12.8% |
| Current State and Local Tax Expense (Benefit) | – | – | – | $139M | – | – |
| Deferred Federal Income Tax Expense (Benefit) | – | – | – | $302M | – | – |
| Deferred Federal, State and Local, Tax Expense (Benefit) | – | – | – | -$229M2024-12-31 | -$354M | +35.3% |
| Deferred Foreign Income Tax Expense (Benefit) | – | – | – | $21M | -$126M | +116.7% |
| Deferred Income Tax Assets, Net | $735M | $844M | -12.9% | $967M | $1.25B | -22.5% |
Source: SEC companyfacts (XBRL of every 10-Q / 10-K). Cash-flow quarters are derived from the year-to-date figures the 10-Q tags. Segment breakdowns are tagged with dimensions and are shown in the segment section instead.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-30, 10-Q 2026-06-30, 10-Q 2026-03-31, 10-K 2025-12-31, 10-Q 2025-09-30, 10-Q 2025-06-30, 10-Q 2025-03-31, 10-K 2024-12-31, 10-Q 2024-09-30
Data as of 2026-11-02